Antibody Firm AxioMx Closes $2M Financing Round
December 07, 2012
Antibody Firm AxioMx Closes $2M Financing Round
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Startup Axiomx Aims to Slash Custom Recombinant Antibody Production Time
April 12, 2013 / ProteoMonitor - New Products: Antibodies from AxioMx
November 16, 2012 / ProteoMonitor - Myriad, DaVita Team on Protein Marker Research
June 17, 2013 / GenomeWeb Daily News - Triple Quads Take the Stage at ASMS 2013 as Vendors Continue Piecing Together Clinical MS Platforms
June 14, 2013 / ProteoMonitor - Thermo Releases New Fusion Mass Spec, Combining Quadrupole, Ion Trap, and Orbitrap in One Instrument
June 14, 2013 / ProteoMonitor